Literature DB >> 22784188

On aspirin treatment but not baseline thromboxane B2 levels predict adverse outcomes in patients with acute coronary syndromes.

E Matsuura, K Guyer, H Yamamoto, L R Lopez, K Inoue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22784188     DOI： 10.1111/j.1538-7836.2012.04845.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  2 in total

Review 1.  Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease.

Authors:  Luis R Lopez; Kirk E Guyer; Ignacio Garcia De La Torre; Kelly R Pitts; Eiji Matsuura; Paul Rj Ames
Journal:  World J Diabetes       Date:  2014-04-15

2.  Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.

Authors:  Francesca Santilli; Leonardo Paloscia; Rossella Liani; Marta Di Nicola; Massimo Di Marco; Stefano Lattanzio; Sara La Barba; Silvia Pascale; Marco Mascellanti; Giovanni Davì
Journal:  J Am Heart Assoc       Date:  2014-07-18       Impact factor: 5.501
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.